Iradimed Co Stock Technical Analysis
| IRMD Stock | USD 99.81 0.03 0.03% |
As of the 14th of February 2026, Iradimed retains the Risk Adjusted Performance of 0.1167, downside deviation of 1.71, and Market Risk Adjusted Performance of 0.5237. Iradimed technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Iradimed jensen alpha, and the relationship between the coefficient of variation and potential upside to decide if Iradimed is priced fairly, providing market reflects its last-minute price of 99.81 per share. Given that Iradimed Co has jensen alpha of 0.2135, we strongly advise you to confirm Iradimed's regular market performance to make sure the company can sustain itself at a future point.
Iradimed Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Iradimed, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IradimedIradimed's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Iradimed Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 120.0 | Strong Buy | 2 | Odds |
Most Iradimed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Iradimed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Iradimed, talking to its executives and customers, or listening to Iradimed conference calls.
Will Health Care Equipment & Supplies sector continue expanding? Could Iradimed diversify its offerings? Factors like these will boost the valuation of Iradimed. Market participants price Iradimed higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Iradimed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.247 | Dividend Share 0.71 | Earnings Share 1.75 | Revenue Per Share | Quarterly Revenue Growth 0.17 |
Iradimed's market price often diverges from its book value, the accounting figure shown on Iradimed's balance sheet. Smart investors calculate Iradimed's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Iradimed's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Iradimed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Iradimed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Iradimed.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Iradimed on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Iradimed Co or generate 0.0% return on investment in Iradimed over 90 days. Iradimed is related to or competes with InMode, Axogen, Tandem Diabetes, Adapthealth Corp, Integra LifeSciences, Claritev, and Opko Health. IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devi... More
Iradimed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Iradimed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Iradimed Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.71 | |||
| Information Ratio | 0.0995 | |||
| Maximum Drawdown | 12.71 | |||
| Value At Risk | (2.44) | |||
| Potential Upside | 2.3 |
Iradimed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Iradimed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Iradimed's standard deviation. In reality, there are many statistical measures that can use Iradimed historical prices to predict the future Iradimed's volatility.| Risk Adjusted Performance | 0.1167 | |||
| Jensen Alpha | 0.2135 | |||
| Total Risk Alpha | 0.106 | |||
| Sortino Ratio | 0.1066 | |||
| Treynor Ratio | 0.5137 |
Iradimed February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1167 | |||
| Market Risk Adjusted Performance | 0.5237 | |||
| Mean Deviation | 1.2 | |||
| Semi Deviation | 1.44 | |||
| Downside Deviation | 1.71 | |||
| Coefficient Of Variation | 725.96 | |||
| Standard Deviation | 1.83 | |||
| Variance | 3.34 | |||
| Information Ratio | 0.0995 | |||
| Jensen Alpha | 0.2135 | |||
| Total Risk Alpha | 0.106 | |||
| Sortino Ratio | 0.1066 | |||
| Treynor Ratio | 0.5137 | |||
| Maximum Drawdown | 12.71 | |||
| Value At Risk | (2.44) | |||
| Potential Upside | 2.3 | |||
| Downside Variance | 2.91 | |||
| Semi Variance | 2.07 | |||
| Expected Short fall | (1.25) | |||
| Skewness | 1.64 | |||
| Kurtosis | 9.71 |
Iradimed Backtested Returns
Iradimed appears to be very steady, given 3 months investment horizon. Iradimed holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Iradimed, which you can use to evaluate the volatility of the firm. Please utilize Iradimed's Market Risk Adjusted Performance of 0.5237, risk adjusted performance of 0.1167, and Downside Deviation of 1.71 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Iradimed holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 0.47, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Iradimed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Iradimed is expected to be smaller as well. Please check Iradimed's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Iradimed's current trending patterns will revert.
Auto-correlation | 0.13 |
Insignificant predictability
Iradimed Co has insignificant predictability. Overlapping area represents the amount of predictability between Iradimed time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Iradimed price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Iradimed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 7.42 |
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Iradimed Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Iradimed across different markets.
About Iradimed Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Iradimed Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Iradimed Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Iradimed price pattern first instead of the macroeconomic environment surrounding Iradimed. By analyzing Iradimed's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Iradimed's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Iradimed specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0221 | 0.0196 | 0.0121 | 0.0115 | Price To Sales Ratio | 9.13 | 9.51 | 14.77 | 7.38 |
Iradimed February 14, 2026 Technical Indicators
Most technical analysis of Iradimed help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Iradimed from various momentum indicators to cycle indicators. When you analyze Iradimed charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1167 | |||
| Market Risk Adjusted Performance | 0.5237 | |||
| Mean Deviation | 1.2 | |||
| Semi Deviation | 1.44 | |||
| Downside Deviation | 1.71 | |||
| Coefficient Of Variation | 725.96 | |||
| Standard Deviation | 1.83 | |||
| Variance | 3.34 | |||
| Information Ratio | 0.0995 | |||
| Jensen Alpha | 0.2135 | |||
| Total Risk Alpha | 0.106 | |||
| Sortino Ratio | 0.1066 | |||
| Treynor Ratio | 0.5137 | |||
| Maximum Drawdown | 12.71 | |||
| Value At Risk | (2.44) | |||
| Potential Upside | 2.3 | |||
| Downside Variance | 2.91 | |||
| Semi Variance | 2.07 | |||
| Expected Short fall | (1.25) | |||
| Skewness | 1.64 | |||
| Kurtosis | 9.71 |
Iradimed February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Iradimed stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,696 | ||
| Daily Balance Of Power | (0.01) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 100.85 | ||
| Day Typical Price | 100.50 | ||
| Price Action Indicator | (1.05) |
Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |